In December 2023, the University of California, Los Angeles, made a significant breakthrough in nanotechnology: nanoparticles from six groups of medium-entropy alloys of palladium, nickel, and platinum. The new material has the potential to improve medium- and high-entropy alloys, which are essential in the manufacturing of strong and tough pieces used across various industries. The alloys find their applications in various fields like building construction, transportation, household appliances, machinery, and electrical devices. Researchers at UCLA are working to improve the alloys' properties with the addition of nanoparticles, including strength, wear resistance, and thermal stability. This finding is forecasted to have a wide-ranging impact on high-performance material industries, which will allow more efficient and powerful technology to be developed.
In April 2021, NanoComposix announced a breakthrough in their technology to scale up the production of 40 nm gold citrate nanoparticles, which will be applied in lateral flow diagnostics. This upgrade increases the capability for production by at least 100 litres at 20 optical densities (OD), greatly increasing output. With these upgraded capabilities, NanoComposix can now produce 30 to 50 million lateral flow strips per month, addressing the growing demand for rapid diagnostic tests, particularly in healthcare applications such as testing for COVID-19. This invention has made NanoComposix a leading market player for diagnostic materials used in different healthcare applications.
In August 2015, Concerning the application of nanotechnology in food ingredients for animal feed, the United States Food and Drug Administration (FDA) published guidelines In ensuring the safety and proper application of food ingredients using nanotechnology, the guidance attempted to clarify the regulatory strategy. It emphasized that companies must inform the FDA of food additive use involving nanomaterials and emphasized the importance of thorough safety assessments. The FDA further indicated that while nanotechnology can have benefits such as improved food safety and delivery of nutrients, it should be determined if there are any potential health effects so that these technologies do not negatively affect animals or, indirectly, humans through the food chain.
In June 2014, the FDA issued three guidelines for the use of nanotechnology in regulated products including cosmetics, food ingredients, and medicine. These guidelines defined the way nanoparticles ought to be tested for safety and effectiveness. The FDA emphasized that manufacturers utilizing nanotechnology in these products have to carry out severe safety testing and ensure their products meet the same regulatory standards as those developed from traditional materials. The FDA emphasized the requirement of safety data concerning the utilization of nanoparticles in dermatological products. For food products, the FDA emphasized pre-marketing approval and labeling, with a call from manufacturers to provide information on potential risks associated with nanotechnology.
The Nanoparticles industry is expanding marvellously globally based on increasing use in different fields.
Nanoparticles have widespread application in the healthcare field, particularly drug delivery systems, because their target specificity to individual cells and tissues increases therapeutic potency. Because of their unique electrical properties, nanoparticles are used an enormous amount in the electronics industry and therefore market growth is fuelled.
Application in paints and coatings is increasing, owing to their capacity to provide UV protection along with antibacterial function. Furthermore, applications in environmental remediation, including water treatment and pollution management, are also fuelling market growth, as the high surface area and reactivity of nanoparticles yield efficient and sustainable solutions.
Sources:
Company: Nano Composix
News outlet: Newsroom UCLA
Research org: Science direct
Contact Us